Advice
Following an abbreviated submission
budesonide inhaler (Easyhaler Budesonide) is accepted for use within NHS Scotland for the treatment of mild, moderate or severe persistent asthma in adults and children over 6 years of age. Easyhaler Budesonide offers an alternative to existing dry powder inhaled formulations of budesonide at a reduced cost.
Download detailed advice30KB (PDF)
Medicine details
- Medicine name:
- Budesonide inhaler 100mcg, 200mcg, 400mcg (Easyhaler® Budesonide)
- SMC ID:
- 241/06
- Indication:
- Asthma
- Pharmaceutical company
- Ranbaxy (UK) Ltd
- BNF chapter
- Respiratory system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 13 March 2006